FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008476989> ?p ?o ?g. }

• W2008476989 endingPage "142S" @default.
• W2008476989 startingPage "137S" @default.
• W2008476989 abstract "The long-term benefit of interferon therapy in chronic hepatitis C is limited. During therapy, serum alanine aminotransferase (ALT) levels decrease to normal and hepatitis C virus (HCV) RNA decreases in 40% to 60% of patients. However, most patients relapse after therapy withdrawal, so that no more than 15% to 25% achieve a sustained response. Re-treatment has been evaluated in studies using different regimens and forms of alpha interferon in different cohorts of patients at different times after initial therapy. Both end-of-treatment and sustained responses to re-treatment correlate with the type of response achieved during the initial course. Patients who do not respond or have only a partial response to the initial course of interferon have an extremely low rate of sustained response when re-treated, independently of the regimen used. Combining data from 13 studies, sustained responses occurred in no patients who were re-treated with 3 million units (MU) three times weekly for 6 months, and in only 2% to 3% of patients re-treated with higher doses and/or for longer periods. In contrast, a significant number of patients who responded during the initial course but subsequently relapsed have a sustained response when re-treated with interferon alone. Combining data from 11 published studies on patients who relapsed after an initial course, sustained responses occurred in 15% (95% confidence interval [CI], 10%-20%) of patients re-treated with 3 MU three times weekly for 6 months, in 29% (CI, 17%-40%) re-treated with a higher dose for 6 months, and in 43% (CI, 34%/50%) re-treated for at least 12 months. On the other hand, patients who relapsed after a 12-month course of interferon had only 4% rate (range, 0%-8%) of sustained response when re-treated. The best predictor of sustained response to re-treatment in patients who had relapsed was a negative serum HCV-RNA test by polymerase chain reaction at the end of the first course. These results, which have been confirmed in a recent prospective, randomized controlled trial, indicate that nonresponders to interferon should not be re-treated with interferon alone, whereas patients who relapse after a 6-month course of alpha interferon therapy have an indication to be re-treated for at least 12 months, especially if serum HCV RNA was negative at the end of the first course of treatment." @default.
• W2008476989 created "2016-06-24" @default.
• W2008476989 creator A5009411535 @default.
• W2008476989 creator A5009702302 @default.
• W2008476989 creator A5014668744 @default.
• W2008476989 creator A5028218642 @default.
• W2008476989 creator A5059809028 @default.
• W2008476989 date "1997-12-01" @default.
• W2008476989 modified "2023-10-16" @default.
• W2008476989 title "Therapy of hepatitis C: Re-treatment with alpha interferon" @default.
• W2008476989 cites W109223073 @default.
• W2008476989 cites W1974763997 @default.
• W2008476989 cites W1994835237 @default.
• W2008476989 cites W2026473365 @default.
• W2008476989 cites W2055302235 @default.
• W2008476989 cites W2069633422 @default.
• W2008476989 cites W2099297588 @default.
• W2008476989 cites W2115641800 @default.
• W2008476989 cites W2117851049 @default.
• W2008476989 cites W2162111530 @default.
• W2008476989 cites W2326597010 @default.
• W2008476989 cites W2334197314 @default.
• W2008476989 cites W2336799715 @default.
• W2008476989 cites W2409853262 @default.
• W2008476989 cites W2411392683 @default.
• W2008476989 cites W97379323 @default.
• W2008476989 cites W1978863475 @default.
• W2008476989 doi "https://doi.org/10.1002/hep.510260724" @default.
• W2008476989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9305679" @default.
• W2008476989 hasPublicationYear "1997" @default.
• W2008476989 type Work @default.
• W2008476989 sameAs 2008476989 @default.
• W2008476989 citedByCount "94" @default.
• W2008476989 countsByYear W20084769892012 @default.
• W2008476989 countsByYear W20084769892013 @default.
• W2008476989 countsByYear W20084769892014 @default.
• W2008476989 crossrefType "journal-article" @default.
• W2008476989 hasAuthorship W2008476989A5009411535 @default.
• W2008476989 hasAuthorship W2008476989A5009702302 @default.
• W2008476989 hasAuthorship W2008476989A5014668744 @default.
• W2008476989 hasAuthorship W2008476989A5028218642 @default.
• W2008476989 hasAuthorship W2008476989A5059809028 @default.
• W2008476989 hasBestOaLocation W20084769891 @default.
• W2008476989 hasConcept C126322002 @default.
• W2008476989 hasConcept C203014093 @default.
• W2008476989 hasConcept C2522874641 @default.
• W2008476989 hasConcept C2776178377 @default.
• W2008476989 hasConcept C2776408679 @default.
• W2008476989 hasConcept C2776455275 @default.
• W2008476989 hasConcept C2776694085 @default.
• W2008476989 hasConcept C2781228144 @default.
• W2008476989 hasConcept C2781413609 @default.
• W2008476989 hasConcept C2909179924 @default.
• W2008476989 hasConcept C3019096185 @default.
• W2008476989 hasConcept C41260117 @default.
• W2008476989 hasConcept C44249647 @default.
• W2008476989 hasConcept C71924100 @default.
• W2008476989 hasConcept C90924648 @default.
• W2008476989 hasConceptScore W2008476989C126322002 @default.
• W2008476989 hasConceptScore W2008476989C203014093 @default.
• W2008476989 hasConceptScore W2008476989C2522874641 @default.
• W2008476989 hasConceptScore W2008476989C2776178377 @default.
• W2008476989 hasConceptScore W2008476989C2776408679 @default.
• W2008476989 hasConceptScore W2008476989C2776455275 @default.
• W2008476989 hasConceptScore W2008476989C2776694085 @default.
• W2008476989 hasConceptScore W2008476989C2781228144 @default.
• W2008476989 hasConceptScore W2008476989C2781413609 @default.
• W2008476989 hasConceptScore W2008476989C2909179924 @default.
• W2008476989 hasConceptScore W2008476989C3019096185 @default.
• W2008476989 hasConceptScore W2008476989C41260117 @default.
• W2008476989 hasConceptScore W2008476989C44249647 @default.
• W2008476989 hasConceptScore W2008476989C71924100 @default.
• W2008476989 hasConceptScore W2008476989C90924648 @default.
• W2008476989 hasIssue "S3" @default.
• W2008476989 hasLocation W20084769891 @default.
• W2008476989 hasLocation W20084769892 @default.
• W2008476989 hasOpenAccess W2008476989 @default.
• W2008476989 hasPrimaryLocation W20084769891 @default.
• W2008476989 hasRelatedWork W1550484024 @default.
• W2008476989 hasRelatedWork W1999400532 @default.
• W2008476989 hasRelatedWork W2004314479 @default.
• W2008476989 hasRelatedWork W2011564592 @default.
• W2008476989 hasRelatedWork W2050318447 @default.
• W2008476989 hasRelatedWork W2062901722 @default.
• W2008476989 hasRelatedWork W2083211870 @default.
• W2008476989 hasRelatedWork W2229086442 @default.
• W2008476989 hasRelatedWork W2418652184 @default.
• W2008476989 hasRelatedWork W3148119108 @default.
• W2008476989 hasVolume "26" @default.
• W2008476989 isParatext "false" @default.
• W2008476989 isRetracted "false" @default.
• W2008476989 magId "2008476989" @default.
• W2008476989 workType "article" @default.